Emily Germain-Lee

Professor, Division Chief of Pediatric Endocrinology

University of Connecticut School of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Emily Germain-Lee is a Professor and the Division Chief of Pediatric Endocrinology at the University of Connecticut School of Medicine in the United States. Her research focuses on bone development and regulation, particularly in conditions such as Albright hereditary osteodystrophy and pseudohypoparathyroidism. She has published recent articles exploring the cellular mechanisms underlying bone ossification and the implications of Gsα inactivation on bone remodeling.

Articles (10)

Year:

2025

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (5)

Gabriel Ángel Martos-Moreno

Assistant Professor

Universidad Autónoma de Madrid

SPAIN

View details

Daniel W. Youngstrom

University of Connecticut Health Center

UNITED STATES

View details

Michael Shen

Columbia University Irving Medical Center

UNITED STATES

View details

Vesa Kaartinen

Professor

University of Michigan

UNITED STATES

View details

Murat Bastepe

Harvard University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Emily Germain-Lee

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Alpha-smooth muscle actin-expressing dermal sheath cells are a major cellular contributor to heterotopic subcutaneous ossifications in a mouse model of Albright hereditary osteodystrophy

Prevalence of Chiari malformation type 1 is increased in pseudohypoparathyroidism type 1A and associated with aberrant bone development

Aberrant Bone Regulation in Albright Hereditary Osteodystrophy dueto Gnas Inactivation: Mechanisms and Translational Implications

Parental Origin of Gsα Inactivation Differentially Affects Bone Remodeling in a Mouse Model of Albright Hereditary Osteodystrophy

Local versus systemic control of bone and skeletal muscle mass by components of the transforming growth factor-β signaling pathway

Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and Patients.

Functional redundancy of type I and type II receptors in the regulation of skeletal muscle growth by myostatin and activin A

Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight.

Legg-Calve-Perthes disease in an 8-year old girl with Acrodysostosis type 1 on growth hormone therapy: case report.

Treatment of rickets and dyslipidemia in twins with progressive familial intrahepatic cholestasis type 2.

Collaborators (5)

Gabriel Ángel Martos-Moreno

Daniel W. Youngstrom

Michael Shen

Vesa Kaartinen

Murat Bastepe

Make your next move.